Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Intra-Cellular Ther (NQ: ITCI )

61.32 UNCHANGED
Streaming Delayed Price Updated: 9:33 AM EDT, Jun 5, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 8,125
Open 61.12
Bid (Size) 61.09 (4)
Ask (Size) 61.53 (4)
Prev. Close 61.32
Today's Range 60.76 - 61.37
52wk Range 42.01 - 66.56
Shares Outstanding 94,324,313
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Recap: Intra-Cellular Therapies Q1 Earnings
 
Via Benzinga
A Preview Of Intra-Cellular Therapies's Earnings
 
Via Benzinga

Performance

YTD
+18.70%
+18.70%
1 Month
-3.13%
-3.13%
3 Month
+28.85%
+28.85%
6 Month
+13.03%
+13.03%
1 Year
+5.36%
+5.36%

More News

Read More
Benzinga's Top Ratings Upgrades, Downgrades For April 20, 2023
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Analyst Ratings for Intra-Cellular Therapies
Via Benzinga
Intra-Cellular Stock Surges As Antipsychotic Shows Benefit In Depression Patients With Mixed Features
Via Benzinga
Analyst Ratings for Intra-Cellular Therapies
Via Benzinga
Airbnb To Rally Around 59%? Here Are 10 Other Analyst Forecasts For Wednesday
Via Benzinga
Why Alibaba Shares Are Trading Higher By Over 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Why Intra-Cellular Therapies Climbed Tuesday
Via The Motley Fool
Earnings Scheduled For March 1, 2023
Via Benzinga
Earnings Outlook For Intra-Cellular Therapies
Via Benzinga
Looking Into Intra-Cellular Therapies's Return On Capital Employed
Via Benzinga
Where Intra-Cellular Therapies Stands With Analysts
Via Benzinga
Intra-Cellular's Big Depression Drug Market Just Got Bigger — And Shares Catapulted
Via Investor's Business Daily
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Biotech Sector Working Fast to Combat Alzheimer’s Disease Cases That are Set to Explode
Via FinancialNewsMedia
Exposures COVID-19
Recap: Intra-Cellular Therapies Q3 Earnings
Via Benzinga
Intra-Cellular Therapies's Earnings: A Preview
Via Benzinga
Looking Into Intra-Cellular Therapies's Return On Capital Employed
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 22, 2022
Via Benzinga
Illumina, Poshmark, Olo And Some Other Big Losers From Friday
Via Benzinga
Biotech Daily: Regulatory Setback For CorMedix, Mersana & GSK In Cancer Pact, BARDA Funding For Opioid Overdose Hopeful
Via Benzinga
Intra-Cellular Therapies: Q2 Earnings Insights
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 7, 2022
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.